322
Participants
Start Date
October 3, 2023
Primary Completion Date
June 26, 2029
Study Completion Date
December 11, 2029
BIIB059 (litifilimab)
Administered as specified in the treatment arm.
University of the Philippines Manila - Philippine General Hospital, Manila
DCC 'Alexandrovska', EOOD, Sofia
DCC Focus 5 - MEOH OOD, Sofia
Lorma Medical Center, San Fernando City, La Union
Hospital de la Santa Creu i Sant Pau, Barcelona
Kantonsspital St. Gallen, Sankt Gallen
Charité - Campus Charité Mitte, Berlin
University Clinical Center of Serbia, Belgrade
Taipei Veterans General Hospital, Taipei
Hospital Universitario Reina Sofia, Córdoba
Karolinska Universitetssjukhuset - Solna, Solna
University of Pennsylvania, Philadelphia
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milan
Klinikum Oldenburg AoeR, Oldenburg
Duke Dermatology South Durham, Durham
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda
Investigacion y Biomedicina de Chihuahua, S.C., Chihuahua City
Hopital Larrey, Toulouse
Centro de investigacion medica y reumatologia, Guadalajara
Hospital Universitario Rio Hortega, Valladolid
Revival Research Institute, LLC, Troy
David Fivenson, MD, Dermatology, PLLC, Ann Arbor
Universitaetsklinikum Muenster, Münster
Fachklinik Bad Bentheim Dermatologie, Bad Bentheim
Università degli studi di Firenze, Florence
Saint Louis University, St Louis
Hopital Edouard Herriot - CHU Lyon, Lyon
Hopital Tenon, Paris
Precision Comprehensive Clinical Research Solutions, Grapevine
Centro de Investigacion Medico Asistencial S.A.S, Barranquilla
Arizona Arthritis & Rheumatology Research, PLLC, Phoenix
Dermatology Research Associates, Los Angeles
Universitaetsklinikum Erlangen, Erlangen
Inland Rheumatology Clinical Trials, Inc., Upland
Beijing Tongren Hospital, Capital Medical University, Beijing
Healthy Medical Center, Zipaquirá
Taichung Veterans General Hospital, Taichung
Shenzhen Second People's Hospital, Shenzhen
Clinical Research Chile SpA, Valdivia
Centro Medico SkinMed, Las Condes
CIEC - Centro Internacional de Estudios Clínicos, Santiago
Thurston Arthritis Research Center, Chapel Hill
UT Southwestern Medical Center, Dallas
Centro de Investigaciones Medicas Tucuman, San Miguel de Tucumán
APRILLUS Asistencia e Investigacion, Buenos Aires
L2IP - Instituto de Pesquisas Clínicas Ltda., Brasília
IPC MT Instituto de Pesquisas Clinicas do Mato Grosso, Santo Ângelo
CMiP - Centro Mineiro de Pesquisa, Juiz de Fora
Nucleo de Pesquisa Clinica do Rio Grande do Sul, Porto Alegre
CEPIC - Centro Paulista de Investigação Clínica e Serviços Médicos, São Paulo
IDERJ - Instituto de Dermatologia e Estética do Brasil Ltda, Rio de Janeiro
Laser Rejuvenation Clinics, Inc., Calgary
DIEX Recherche Sherbrooke Inc., Sherbrooke
Universitaetsklinikum Carl Gustav Carus TU, Dresden
Universitaetsklinikum Halle (Saale), Halle
Pecsi Tudomanyegyetem Klinikai Kozpont, Pécs
University of Fukui Hospital, Yoshida-gun
Hospital of the University of Occupational and Environmental Health, Kitakyushu-shi
Kakogawa Central City Hospital, Kakogawa-shi
Kanazawa University Hospital, Kanazawa
Kumamoto University Hospital, Kumamoto
Niigata University Medical & Dental Hospital, Niigata
Osaka Keisatsu Hospital, Osaka
Teikyo University Hospital, Itabashi-ku
Clinstile, S.A. de C.V., Mexico City
Artromac n.o., Košice
Hanyang University Seoul Hospital, Seoul
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne
Whipps Cross University Hospital, London
Queen Elizabeth Hospital, Birmingham
Chapel Allerton Hospital, Chapel Allerton
Lead Sponsor
Biogen
INDUSTRY